Marc Scherlinger

1.7k total citations · 1 hit paper
40 papers, 910 citations indexed

About

Marc Scherlinger is a scholar working on Rheumatology, Immunology and Oncology. According to data from OpenAlex, Marc Scherlinger has authored 40 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Rheumatology, 18 papers in Immunology and 9 papers in Oncology. Recurrent topics in Marc Scherlinger's work include Systemic Lupus Erythematosus Research (15 papers), T-cell and B-cell Immunology (11 papers) and Immune Cell Function and Interaction (6 papers). Marc Scherlinger is often cited by papers focused on Systemic Lupus Erythematosus Research (15 papers), T-cell and B-cell Immunology (11 papers) and Immune Cell Function and Interaction (6 papers). Marc Scherlinger collaborates with scholars based in France, United States and Canada. Marc Scherlinger's co-authors include Christophe Richez, Patrick Blanco, George C. Tsokos, Éric Boilard, Thierry Schaeverbeke, Renaud Felten, Laurent Arnaud, Marie‐Elise Truchetet, Estibaliz Lazaro and Jean Sibilia and has published in prestigious journals such as Nature Communications, Nature reviews. Immunology and The Journal of Immunology.

In The Last Decade

Marc Scherlinger

39 papers receiving 897 citations

Hit Papers

The role of platelets in immune-mediated inflammatory dis... 2023 2026 2024 2025 2023 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Scherlinger France 16 401 274 136 112 110 40 910
Adriana María Kakehasi Brazil 17 233 0.6× 447 1.6× 102 0.8× 65 0.6× 172 1.6× 102 1.0k
Chiara Crotti Italy 17 231 0.6× 501 1.8× 146 1.1× 159 1.4× 176 1.6× 56 1.1k
Andra Bălănescu Romania 18 397 1.0× 645 2.4× 117 0.9× 155 1.4× 224 2.0× 79 1.2k
Marcus Köller Austria 16 234 0.6× 304 1.1× 97 0.7× 107 1.0× 89 0.8× 38 857
Nicola Ughi Italy 17 133 0.3× 281 1.0× 84 0.6× 71 0.6× 90 0.8× 49 862
May Y. Choi Canada 16 303 0.8× 467 1.7× 89 0.7× 41 0.4× 53 0.5× 78 785
W. Demary Germany 9 280 0.7× 756 2.8× 66 0.5× 98 0.9× 333 3.0× 16 1.3k
Gülsüm Emel Pamuk Türkiye 18 200 0.5× 185 0.7× 212 1.6× 150 1.3× 186 1.7× 65 984
Mariko Ishimori United States 18 456 1.1× 726 2.6× 134 1.0× 68 0.6× 154 1.4× 61 1.2k
Arvind Kaul United Kingdom 10 568 1.4× 761 2.8× 195 1.4× 118 1.1× 79 0.7× 37 1.4k

Countries citing papers authored by Marc Scherlinger

Since Specialization
Citations

This map shows the geographic impact of Marc Scherlinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Scherlinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Scherlinger more than expected).

Fields of papers citing papers by Marc Scherlinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Scherlinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Scherlinger. The network helps show where Marc Scherlinger may publish in the future.

Co-authorship network of co-authors of Marc Scherlinger

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Scherlinger. A scholar is included among the top collaborators of Marc Scherlinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Scherlinger. Marc Scherlinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Felten, Renaud, Kévin Bigaut, Laurent Kremer, et al.. (2025). Advancing medical training with augmented reality and haptic feedback simulator: outcomes of a randomized controlled trial on lumbar puncture. BMC Medical Education. 25(1). 1231–1231. 1 indexed citations
3.
Scherlinger, Marc, Antonios G.A. Kolios, Vasileios C. Kyttaris, & George C. Tsokos. (2025). Advances in the treatment of systemic lupus erythematosus. Nature Reviews Drug Discovery. 24(12). 926–944. 1 indexed citations
4.
Avouac, Jérôme, et al.. (2024). CAR T-Cell Therapy for Rheumatic Diseases: What Does the Future Hold?. BioDrugs. 39(1). 5–19. 1 indexed citations
5.
Scherlinger, Marc, Hao Li, Wenliang Pan, et al.. (2024). CaMK4 controls follicular helper T cell expansion and function during normal and autoimmune T-dependent B cell responses. Nature Communications. 15(1). 840–840. 10 indexed citations
6.
Scherlinger, Marc, Christophe Richez, George C. Tsokos, Éric Boilard, & Patrick Blanco. (2023). Author Correction: The role of platelets in immune-mediated inflammatory diseases. Nature reviews. Immunology. 23(6). 409–409. 6 indexed citations
7.
Sibilia, Jean, et al.. (2023). Mind-body practices in chronic inflammatory arthritis. Joint Bone Spine. 91(3). 105645–105645. 5 indexed citations
8.
Felten, Renaud, Marc Scherlinger, Philippe Mertz, François Chasset, & Laurent Arnaud. (2023). New biologics and targeted therapies in systemic lupus: From new molecular targets to new indications. A systematic review. Joint Bone Spine. 90(2). 105523–105523. 27 indexed citations
9.
Askanase, Anca, Wei Tang, Philippe Mertz, et al.. (2023). New and future therapies: Changes in the therapeutic armamentarium for SLE. Best Practice & Research Clinical Rheumatology. 37(4). 101865–101865. 9 indexed citations
10.
Scherlinger, Marc, Wenliang Pan, Ryo Hisada, et al.. (2022). Phosphofructokinase P fine-tunes T regulatory cell metabolism, function, and stability in systemic autoimmunity. Science Advances. 8(48). eadc9657–eadc9657. 34 indexed citations
11.
Hisada, Ryo, Nobuya Yoshida, Masataka Umeda, et al.. (2022). Role of Glutaminase 2 in Promoting CD4+ T Cell Production of Interleukin‐2 by Supporting Antioxidant Defense in Systemic Lupus Erythematosus. Arthritis & Rheumatology. 74(7). 1204–1210. 12 indexed citations
12.
Hisada, Ryo, Nobuya Yoshida, Masataka Umeda, et al.. (2022). The deacetylase SIRT2 contributes to autoimmune disease pathogenesis by modulating IL-17A and IL-2 transcription. Cellular and Molecular Immunology. 19(6). 738–750. 22 indexed citations
13.
Scherlinger, Marc, Cédric Lemogne, Renaud Felten, & Jean Sibilia. (2022). Excess of Post-Acute Sequelae of COVID-19 After the First Wave of the Pandemic. Infectious Diseases and Therapy. 11(6). 2279–2285. 10 indexed citations
14.
Scherlinger, Marc & George C. Tsokos. (2021). Reactive oxygen species: The Yin and Yang in (auto-)immunity. Autoimmunity Reviews. 20(8). 102869–102869. 26 indexed citations
15.
Scherlinger, Marc, et al.. (2020). Characteristics and opinions of MD-PhD students and graduates from different European countries: a study from the European MD-PhD Association. Swiss Medical Weekly. 150(1516). w20205–w20205. 7 indexed citations
16.
Scherlinger, Marc, et al.. (2020). Ascorbate maintains a low plasma oxygen level. Scientific Reports. 10(1). 10659–10659. 8 indexed citations
17.
Scherlinger, Marc, et al.. (2020). Role of stress in the development of rheumatoid arthritis: a case–control study. Lara D. Veeken. 60(2). 629–637. 8 indexed citations
18.
Comarmond, Cloé, Nathalie Saidenberg-Kermanac’h, N. Schleinitz, et al.. (2019). Osseous sarcoidosis: A multicenter retrospective case-control study of 48 patients. Joint Bone Spine. 86(6). 789–793. 19 indexed citations
19.
Brilland, Benoît, Marc Scherlinger, Liliane Khoryati, et al.. (2019). Platelets and IgE: Shaping the Innate Immune Response in Systemic Lupus Erythematosus. Clinical Reviews in Allergy & Immunology. 58(2). 194–212. 19 indexed citations
20.
Jacquemin, C., Jean‐François Augusto, Marc Scherlinger, et al.. (2018). OX40L/OX40 axis impairs follicular and natural Treg function in human SLE. JCI Insight. 3(24). 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026